FindTrial
Sign In

OBSERVATION CHANGES OF SAFETY PARAMETER AFTER ADMINISTERTATION OF SIDDHA METAL AND MINERAL MEDICINES

OBSERVATION OF SAFETY PARAMETERS IN PATIENT ADMINISTERING WITH SIDDHA METAL AND MINERAL MEDICINES FOR LONGER PERIOD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014266
Enrollment
150
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R78- Findings of drugs and other substances, not normally found in blood Health Condition 2: null- Nil

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Ayothidoss Pandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients prescribed with Siddha metal or/and mineral formulation for more than 40 days and availability of those patientsâ?? blood parameters at the time of admission and discharge.

Exclusion criteria

Exclusion criteria: Non availability of record of chronic illness related to liver and renal disorders,etc Case sheet of patients prescribed with herbal medicines alone

Design outcomes

Primary

MeasureTime frame
Provide Information about Parameter change in Patient Administering with Siddha Metal and Mineral Medicines for longer period and Measures to be taken to strengthen the quality of health serviceTimepoint: 20min—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr C Rahini Nivedhidha

National Institute of Siddha

svisu11@gmail.com9944890608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026